| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
1e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
| mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |
| mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |